Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …

With over 100 trillion microbial cells, the gut microbiome plays important roles in both the
maintenance of health and the pathogenesis of disease. Gut microbiome dysbiosis, resulted …

There is increasing interest in the therapeutic potential of manipulating the gut microbiome
of patients with chronic kidney disease (CKD). This is because there is a substantial …

Interest in gut microbiome dysbiosis and its potential association with the development and
progression of chronic kidney disease (CKD) has increased substantially in the past 6 years …

The gut microbiota consists of trillions of microorganisms, fulfilling important roles in
metabolism, nutritional intake, physiology and maturation of the immune system, but also …

The human gut harbors> 100 trillion microbial cells, which influence the nutrition,
metabolism, physiology, and immune function of the host. Here, we review the quantitative …

Chronic kidney disease (CKD) affects more than 10% population worldwide and becomes a
huge burden to the world. Recent studies have revealed multifold interactions between CKD …

The complicated communities of microbiota colonizing the human gastrointestinal tract exert
a strong function in health maintenance and disease prevention. Indeed, accumulating …

Chronic kidney disease (CKD) is a worldwide public health issue and has ultimately
progressed to an end-stage renal disease that requires life-long dialysis or renal …

Microbiome modulation as a novel therapeutic approach in chr... : Current Opinion in
Nephrology and Hypertension Microbiome modulation as a novel therapeutic approach in …